News and media

Help raise awareness about cervical screening and the Cervical Screening Test self-collection option.

Healthcare providers, make sure you’re up to date on upcoming changes to the National Cervical Screening Program clinical guidelines.

We have sent cancer screening packs to more than 7,000 general practices, and are seeking your help to promote our life-saving cancer screening programs.

Important information for healthcare providers and pathology laboratories regarding changes to the ‘Requirements for Cervical Screening (First edition 2023)’ from 1 August 2024.

NACCHO are hosting two CPD accredited webinars for healthcare workers on the cervical screening self-collection option. The webinars will focus on how to support Aboriginal and/or Torres Strait Islander women and people with a cervix in their cervical screening.

Healthcare providers are invited to attend a webinar on best practice cervical screening for people with disability.

Healthcare practices and clinics offering cervical screening are encouraged to set themselves up to support patient screening choice.

Christmas, summer and the festive season is a time many of us spend with our family and friends. Make sure you know the basics and protect yourself, family and friends from COVID-19.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.

Australia now has a national strategy to help us achieve our goal of eliminating cervical cancer by 2035 – the first country in the world to do so.

The Australian Technical Advisory Group on Immunisation (ATAGI) recently updated their advice for the COVID-19 booster dose.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding an additional COVID-19 dose for highest risk people in 2023. These recommendations are in addition to the previous ATAGI COVID-19 vaccine booster advice published in February 2023.

Healthcare providers – build knowledge and skills to offer your patients the self-collection option for cervical screening HPV testing.

ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course.

The Australian Government has launched a new advertising campaign to encourage adults to get a COVID-19 booster if it has been 6 months or more since their last COVID-19 vaccination or infection.

It’s easy to forget about cancer screening. But detecting cancer early saves lives. Learn more about cancer screening programs and how to enter the Beautiful Shawl competition.

The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years (Pfizer 6 months to 4 years).

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November 2022.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.